Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci Sells 818 Shares

Tempus AI, Inc. (NASDAQ:TEM) CAO Ryan M. Bartolucci sold 818 shares of Tempus AI stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $81.87, for a total value of $66,969.66. Following the completion of the transaction, the chief accounting officer now owns 46,182 shares in the company, valued at $3,780,920.34. This trade represents a 1.74 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink.

Tempus AI Stock Down 11.2 %

Shares of TEM stock opened at $68.09 on Friday. The stock has a fifty day moving average price of $50.29 and a 200 day moving average price of $51.72. Tempus AI, Inc. has a 1 year low of $22.89 and a 1 year high of $91.45. The company has a quick ratio of 2.55, a current ratio of 2.69 and a debt-to-equity ratio of 8.17.

Wall Street Analyst Weigh In

Several research analysts have weighed in on the company. Guggenheim assumed coverage on Tempus AI in a research note on Monday, December 9th. They issued a “buy” rating and a $74.00 target price on the stock. William Blair cut Tempus AI from an “outperform” rating to a “market perform” rating in a report on Wednesday, February 12th. Loop Capital reduced their price target on Tempus AI from $57.00 to $52.00 and set a “buy” rating for the company in a report on Tuesday, January 14th. Wolfe Research assumed coverage on Tempus AI in a report on Friday, December 13th. They issued an “outperform” rating and a $60.00 price target for the company. Finally, Bank of America raised their price target on Tempus AI from $52.00 to $54.00 and gave the company a “neutral” rating in a report on Friday, December 13th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the company. According to MarketBeat, Tempus AI currently has a consensus rating of “Moderate Buy” and an average price target of $58.55.

Hedge Funds Weigh In On Tempus AI

Several hedge funds and other institutional investors have recently bought and sold shares of TEM. ARK Investment Management LLC raised its holdings in Tempus AI by 132.1% during the fourth quarter. ARK Investment Management LLC now owns 5,519,644 shares of the company’s stock worth $186,343,000 after purchasing an additional 3,141,487 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. raised its holdings in Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Nikko Asset Management Americas Inc. raised its holdings in Tempus AI by 166.0% during the fourth quarter. Nikko Asset Management Americas Inc. now owns 3,239,093 shares of the company’s stock worth $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Franklin Resources Inc. raised its holdings in Tempus AI by 240.5% during the fourth quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company’s stock worth $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. Finally, JPMorgan Chase & Co. raised its holdings in Tempus AI by 86,947.2% during the fourth quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company’s stock worth $55,836,000 after purchasing an additional 1,651,996 shares during the last quarter. 24.22% of the stock is owned by institutional investors and hedge funds.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.